AAGH — America Great Health Cashflow Statement
0.000.00%
- $120.86m
- $123.28m
- $0.29m
- 31
- 22
- 26
- 14
Annual cashflow statement for America Great Health, fiscal year end - June 30th, USD millions except per share, conversion factor applied.
2020 June 30th | 2021 June 30th | 2022 June 30th | C2023 June 30th | 2024 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | -0.052 | -0.269 | -4.92 | -0.777 | -1.23 |
Depreciation | |||||
Non-Cash Items | 0.005 | 0.016 | 1.43 | 0.011 | 0.101 |
Unusual Items | |||||
Equity in Net Earnings/Losses | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | 0.007 | -0.076 | 2 | 0.367 | 0.495 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Prepaid Expenses | |||||
Change in Other Assets | |||||
Change in Accounts Payable | |||||
Change in Accrued Expenses | |||||
Change in Payable / Accrued Expenses | |||||
Change in Taxes Payable | |||||
Change in Other Liabilities | |||||
Cash from Operating Activities | -0.04 | -0.329 | -1.48 | -0.39 | -0.616 |
Capital Expenditures | — | -0.013 | -0.017 | -0.044 | 0 |
Purchase of Fixed Assets | |||||
Cash from Investing Activities | — | -0.013 | -0.017 | -0.044 | 0 |
Financing Cash Flow Items | 0.04 | 0.156 | 0.242 | -0.212 | 0.617 |
Other Financing Cash Flow | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 0.04 | 0.738 | 1.16 | 0.426 | 0.617 |
Foreign Exchange Effects | |||||
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 0 | 0.396 | -0.333 | -0.008 | 0.001 |